Lisaftoclax (compound 6) 是 Bcl-2 和Bcl-xl 的双抑制剂，信息来自专利 WO2018027097A1。Lisaftoclax 对Bcl-2 和Bcl-xl 的IC50 值分别为 2 nM 和 5.9 nM。
货号:ajcx37672
CAS:2180923-05-9
分子式:C45H48ClN7O8S
分子量：882.42
溶解度:N/A
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Lisaftoclax (compound 6) is a dual Bcl-2 and Bcl-xl inhibitor with anti-tumor activity, extracted from patent WO2018027097A1. Lisaftoclax exhibits IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl, respectively[1].

Lisaftoclax (compound 6) exhibits IC50 values of 5.5 nM and 6.4 nM in Bcl-2 dependent RS4;11 cells and Bcl-xl dependent Molm13 cells[1].

[1]. WANG, Chia, et al. N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS. Patent. WO2018027097A1.